These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 10841023
1. Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies. Costa A, Conget I, Casamitjana R. Diabetes Care; 2000 Jun; 23(6):874. PubMed ID: 10841023 [No Abstract] [Full Text] [Related]
2. Islet autoantibodies and their use in predicting insulin-dependent diabetes. Bonifacio E, Bingley PJ. Acta Diabetol; 1997 Oct; 34(3):185-93. PubMed ID: 9401639 [No Abstract] [Full Text] [Related]
3. Use of self-collected capillary blood samples for islet autoantibody screening in relatives: a feasibility and acceptability study. Liu Y, Rafkin LE, Matheson D, Henderson C, Boulware D, Besser REJ, Ferrara C, Yu L, Steck AK, Bingley PJ, Type 1 Diabetes TrialNet Study Group. Diabet Med; 2017 Jul; 34(7):934-937. PubMed ID: 28226181 [Abstract] [Full Text] [Related]
5. Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study. Raab J, Haupt F, Scholz M, Matzke C, Warncke K, Lange K, Assfalg R, Weininger K, Wittich S, Löbner S, Beyerlein A, Nennstiel-Ratzel U, Lang M, Laub O, Dunstheimer D, Bonifacio E, Achenbach P, Winkler C, Ziegler AG, Fr1da Study Group. BMJ Open; 2016 May 18; 6(5):e011144. PubMed ID: 27194320 [Abstract] [Full Text] [Related]
11. Birth and coming of age of islet autoantibodies. Bonifacio E, Achenbach P. Clin Exp Immunol; 2019 Dec 18; 198(3):294-305. PubMed ID: 31397889 [Abstract] [Full Text] [Related]
12. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes]. Bieg S, Seissler J, Scherbaum WA. Med Klin (Munich); 1995 Oct 15; 90(10):594-8. PubMed ID: 7500923 [No Abstract] [Full Text] [Related]
13. Prevalence of GAD65 and IA-2 autoantibodies in IDDM patients affected by diabetic nephropathy. Zerbini G, Bazzigaluppi E, Mangili R, Bosi E, Bonifacio E. Diabetologia; 1997 Apr 15; 40(4):485. PubMed ID: 9112029 [No Abstract] [Full Text] [Related]
14. Isotypes of anti-islet autoantibodies. Eisenbarth GS. Diabetes Care; 2000 Feb 15; 23(2):151-2. PubMed ID: 10868822 [No Abstract] [Full Text] [Related]
15. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. Velloso LA, Kämpe O, Hallberg A, Christmanson L, Betsholtz C, Karlsson FA. J Clin Invest; 1993 May 15; 91(5):2084-90. PubMed ID: 8486775 [Abstract] [Full Text] [Related]
16. Type 1 diabetes islet autoantibody markers. Winter WE, Harris N, Schatz D. Diabetes Technol Ther; 2002 May 15; 4(6):817-39. PubMed ID: 12614488 [Abstract] [Full Text] [Related]
17. [Autoantibodies against GAD, GAD65 and IA-2]. Tsujii S. Nihon Rinsho; 2002 Aug 15; 60 Suppl 8():395-400. PubMed ID: 12355780 [No Abstract] [Full Text] [Related]
18. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function. Fukui M, Nakamura N, Nakano K, Kondo M. Diabetes Care; 1999 Oct 15; 22(10):1758-9. PubMed ID: 10526760 [No Abstract] [Full Text] [Related]
19. Proposed guidelines on screening for risk of type 1 diabetes. Bingley PJ, Bonifacio E, Ziegler AG, Schatz DA, Atkinson MA, Eisenbarth GS, Immunology of Diabetes Society. Diabetes Care; 2001 Feb 15; 24(2):398. PubMed ID: 11213898 [No Abstract] [Full Text] [Related]
20. Cytoplasmic islet cell antibodies (ICA): towards a molecular understanding of the autoantigens. Scherbaum WA. Clin Endocrinol (Oxf); 1994 Jan 15; 40(1):15-8. PubMed ID: 7508344 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]